FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
A nationwide recall of enchiladas has been announced after the U.S. Food and Drug Administration (FDA) identified a potential ...
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...
Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...
A Class I recall is used when "a violative product will cause serious adverse health consequences or death," according to the ...
The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count ...
More than three years after Novartis’ plan for a speedy approval for intrathecal Zolgensma was thwarted by an FDA requirement ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...
Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...
The FDA announced Monday it has begun collecting samples of aged raw cow's milk cheese to test for bird flu as the U.S. battles an outbreak of the virus.
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening ...